Breaking News Instant updates and real-time market news.

ACOR

Acorda Therapeutics

$6.91 /

+0.5 (+7.80%)

16:05
03/04/21
03/04
16:05
03/04/21
16:05

Acorda Therapeutics reports Q4 EPS ($2.50), one estimate ($1.48)

Reports Q4 revenue $38.2M, one estimate $34M. "We have improved our financial position materially through the sale of our manufacturing operations in Chelsea and our restructuring, which also have reduced both our annual operating expenses and cost of goods for INBRIJA," said Ron Cohen, CEO. "In 2020, we continued to improve access to INBRIJA and saw excellent results from our new patient education and training programs; for example, approximately 1,250 patients who had either never filled or had discontinued their original INBRIJA prescriptions responded to our educational outreach and training by returning to therapy. We also saw quarter over quarter growth in INBRIJA despite the substantial negative impact of COVID-19, and believe we are well-positioned for further growth when the pandemic subsides. We also believe that the reduced cost of goods for INBRIJA will help potentiate commercial partnerships outside the US."

  • 04

    Mar

ACOR Acorda Therapeutics
$6.91 /

+0.5 (+7.80%)

01/13/21 Cowen
Acorda Therapeutics price target raised to $35 from $5 at Cowen

TODAY'S FREE FLY STORIES

General news
Fed Chair Powell reiterated the FOMC will continue to support the recovery » 08:38
04/12/21
04/12
08:38
04/12/21
08:38
$ECON

Economic Data

/

+

Fed Chair Powell…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    Downgrade
    Argo Group downgraded to Neutral from Outperform at Boenning & Scattergood » 08:38
    04/12/21
    04/12
    08:38
    04/12/21
    08:38
    ARGO

    Argo Group

    $54.05 /

    -0.13 (-0.24%)

    Boenning &…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ARGO Argo Group
    $54.05 /

    -0.13 (-0.24%)

    ARGO Argo Group
    $54.05 /

    -0.13 (-0.24%)

    03/15/21 HSBC
    Argo Group price target raised to $10.25 from $7 at HSBC
    03/15/21 Compass Point
    Argo Group upgraded to Buy from Neutral at Compass Point
    01/06/21 Compass Point
    Argo Group price target raised to $47 from $41 at Compass Point
    11/11/20 Compass Point
    Argo Group downgraded to Neutral after vaccine-fueled rally at Compass Point
    ARGO Argo Group
    $54.05 /

    -0.13 (-0.24%)

    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    Talend: 'Go-shop' period expires related to Thoma Bravo acquistion » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    TLND

    Talend

    $64.71 /

    +0.27 (+0.42%)

    Talend announced the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    03/11/21
    Fly Intel: Top five analyst downgrades
    03/11/21 Needham
    Talend downgraded to Hold from Buy at Needham
    03/10/21 Craig-Hallum
    Talend go-shop 'could spark interest,' says Craig-Hallum
    03/10/21 William Blair
    Talend downgraded to Market Perform from Outperform at William Blair
    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    TLND Talend
    $64.71 /

    +0.27 (+0.42%)

    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Recommendations
    Alibaba named a Research Tactical Idea at Morgan Stanley » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    BABA

    Alibaba

    $223.35 /

    -4.9 (-2.15%)

    Morgan Stanley analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    07:37 Today Raymond James
    Alibaba price target lowered to $330 from $350 at Raymond James
    06:41 Today Mizuho
    Alibaba antitrust ruling 'removes overhang,' says Mizuho
    06:37 Today Citi
    Alibaba fine could help lift 'overhang' on shares, says Citi
    06:36 Today KeyBanc
    Alibaba price target lowered to $305 from $315 at KeyBanc
    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    BABA Alibaba
    $223.35 /

    -4.9 (-2.15%)

    Hot Stocks
    Rayonier Advanced Materials to sell lumber, newsprint assets to GreenFirst » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    RYAM

    Rayonier Advanced Materials

    $9.66 /

    -0.05 (-0.51%)

    Rayonier Advanced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    RYAM Rayonier Advanced Materials
    $9.66 /

    -0.05 (-0.51%)

    RYAM Rayonier Advanced Materials
    $9.66 /

    -0.05 (-0.51%)

    10/20/20
    Fly Intel: Top five analyst upgrades
    10/20/20 RBC Capital
    Rayonier Advanced Materials upgraded to Outperform at RBC Capital
    10/20/20 RBC Capital
    Rayonier Advanced upgraded to Outperform from Sector Perform at RBC Capital
    06/19/20
    Fly Intel: Top five analyst upgrades
    RYAM Rayonier Advanced Materials
    $9.66 /

    -0.05 (-0.51%)

    RYAM Rayonier Advanced Materials
    $9.66 /

    -0.05 (-0.51%)

    Hot Stocks
    Genprex collaborators report data for REQORSA therapy in NSLC treatment » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    GNPX

    Genprex

    $4.46 /

    -0.415 (-8.51%)

    Genprex announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    GNPX Genprex
    $4.46 /

    -0.415 (-8.51%)

    01/26/21 National Securities
    Genprex initiated with a Buy at National Securities
    04/22/20 Alliance Global Partners
    Genprex initiated with a Buy at Alliance Global Partners
    Hot Stocks
    TC Energy announces issuance of renewable energy RFI » 08:37
    04/12/21
    04/12
    08:37
    04/12/21
    08:37
    TRP

    TC Energy

    $46.80 /

    -0.24 (-0.51%)

    TC Energy Corporation…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    TRP TC Energy
    $46.80 /

    -0.24 (-0.51%)

    TRP TC Energy
    $46.80 /

    -0.24 (-0.51%)

    03/19/21 Evercore ISI
    TC Energy resumed with an In Line at Evercore ISI
    03/01/21 Wells Fargo
    TC PipeLines downgraded to Equal Weight from Overweight at Wells Fargo
    02/19/21 TD Securities
    TC Energy price target lowered to C$73 from C$75 at TD Securities
    02/19/21 CIBC
    TC Energy price target raised to C$70 from C$69 at CIBC
    TRP TC Energy
    $46.80 /

    -0.24 (-0.51%)

    TRP TC Energy
    $46.80 /

    -0.24 (-0.51%)

    Hot Stocks
    Medigus says Polyrizon commences pre-clinical study of bio-gel » 08:35
    04/12/21
    04/12
    08:35
    04/12/21
    08:35
    MDGS

    Medigus

    $2.03 /

    -0.035 (-1.70%)

    Medigus announced that…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    MDGS Medigus
    $2.03 /

    -0.035 (-1.70%)

    • 11
      Jan
    • 02
      Dec
    • 20
      May
    Hot Stocks
    Microsoft to acquire Nuance for $56.00 per share in cash, or $19.7B » 08:35
    04/12/21
    04/12
    08:35
    04/12/21
    08:35
    MSFT

    Microsoft

    $255.73 /

    +2.37 (+0.94%)

    , NUAN

    Nuance

    $45.59 /

    +0.38 (+0.84%)

    Microsoft (MSFT) and…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    07:11 Today BMO Capital
    Microsoft price target raised to $280 from $270 at BMO Capital
    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    08:30 Today Stifel
    Microsoft a 'logical buyer' of Nuance, says Stifel
    07:36 Today B. Riley
    Nuance possible takeout positive for peer LivePerson, says B. Riley
    07:29 Today Wedbush
    Nuance deal would be 'trophy' for Microsoft, says Wedbush
    03/10/21 Wedbush
    Nuance added to Best Ideas List at Wedbush
    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    MSFT Microsoft
    $255.73 /

    +2.37 (+0.94%)

    NUAN Nuance
    $45.59 /

    +0.38 (+0.84%)

    General news
    Oil Action: WTI crude » 08:35
    04/12/21
    04/12
    08:35
    04/12/21
    08:35
    $ECON

    Economic Data

    /

    +

    Oil Action: WTI crude is…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
      Hot Stocks
      Artelo Biosciences doses first patient in CAReS study with ART27.13 » 08:34
      04/12/21
      04/12
      08:34
      04/12/21
      08:34
      ARTL

      Artelo Biosciences

      $1.53 /

      -0.055 (-3.47%)

      Artelo Biosciences…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      ARTL Artelo Biosciences
      $1.53 /

      -0.055 (-3.47%)

      ARTL Artelo Biosciences
      $1.53 /

      -0.055 (-3.47%)

      02/12/21 Ladenburg
      Artelo Biosciences initiated with a Buy at Ladenburg
      01/07/21 Maxim
      Artelo Biosciences upgraded to Buy from Hold at Maxim
      01/07/21 Maxim
      Artelo Biosciences upgraded to Buy from Hold at Maxim
      05/13/20 Maxim
      Artelo Biosciences downgraded to Hold from Buy at Maxim
      ARTL Artelo Biosciences
      $1.53 /

      -0.055 (-3.47%)

      • 09
        Oct
      Recommendations
      Chicken Soup for the Soul price target raised to $48 from $35 at Craig-Hallum » 08:34
      04/12/21
      04/12
      08:34
      04/12/21
      08:34
      CSSE

      Chicken Soup for the Soul

      $32.50 /

      +4.54 (+16.24%)

      Craig-Hallum analyst…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      CSSE Chicken Soup for the Soul
      $32.50 /

      +4.54 (+16.24%)

      CSSE Chicken Soup for the Soul
      $32.50 /

      +4.54 (+16.24%)

      08:23 Today Northland
      Chicken Soup for the Soul price target raised to $40 from $30 at Northland
      04/09/21 Alliance Global Partners
      Alliance Global raises Chicken Soup for the Soul price target to $48 after deal
      04/01/21 DA Davidson
      Chicken Soup for the Soul price target raised to $34 from $28 at DA Davidson
      04/01/21 Craig-Hallum
      Chicken Soup for the Soul price target raised to $35 from $30 at Craig-Hallum
      Hot Stocks
      Infinity Energy completes purchase of production, acresin Central Kansas Uplift » 08:33
      04/12/21
      04/12
      08:33
      04/12/21
      08:33
      IFNY

      Infinity Energy Resources

      /

      +

      Infinity Energy Resources…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      Recommendations
      B. Riley calls Agenus the next Seagen, reiterates $8 target » 08:33
      04/12/21
      04/12
      08:33
      04/12/21
      08:33
      AGEN

      Agenus

      $2.78 /

      -0.01 (-0.36%)

      , MRK

      Merck

      $76.33 /

      +0.855 (+1.13%)

      , BMY

      Bristol-Myers

      $62.61 /

      +0.695 (+1.12%)

      , AZN

      AstraZeneca

      $49.95 /

      +0.465 (+0.94%)

      , RHHBY

      Roche

      $41.93 /

      +0.53 (+1.28%)

      , SGEN

      Seagen

      $142.81 /

      -1.68 (-1.16%)

      B. Riley analyst Mayank…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      AGEN Agenus
      $2.78 /

      -0.01 (-0.36%)

      MRK Merck
      $76.33 /

      +0.855 (+1.13%)

      BMY Bristol-Myers
      $62.61 /

      +0.695 (+1.12%)

      AZN AstraZeneca
      $49.95 /

      +0.465 (+0.94%)

      RHHBY Roche
      $41.93 /

      +0.53 (+1.28%)

      SGEN Seagen
      $142.81 /

      -1.68 (-1.16%)

      AGEN Agenus
      $2.78 /

      -0.01 (-0.36%)

      09/22/20 B. Riley FBR
      B. Riley FBR calls Agenus 'hidden gem' amidst ESMO data releases
      09/18/20 Jefferies
      Agenus price target raised to $8 from $5 at Jefferies
      MRK Merck
      $76.33 /

      +0.855 (+1.13%)

      04/08/21 Alliance Global Partners
      Alliance Global Partners sees Fast Track for Immutep efti as meaningful positive
      04/08/21 H.C. Wainwright
      Alkermes collaboration not as big as investors wanted, says H.C. Wainwright
      04/07/21 Mizuho
      Mizuho sees Alkermes, Merck collaboration as important next step for nemvaleukin
      04/06/21 RBC Capital
      Merck transferred with a Sector Perform at RBC Capital
      BMY Bristol-Myers
      $62.61 /

      +0.695 (+1.12%)

      03/08/21 BofA
      Gartner added to US 1 List, Bristol-Myers removed at BofA
      02/12/21 Morgan Stanley
      Amgen court decision may have readthrough for Gilead, says Morgan Stanley
      02/02/21 BTIG
      Prothena upgraded to Buy at BTIG on birtamimab 'revival'
      01/20/21 William Blair
      Exelixis selloff on competitive concerns an 'overreaction,' says William Blair
      AZN AstraZeneca
      $49.95 /

      +0.465 (+0.94%)

      07:18 Today Argus
      AstraZeneca downgraded to Hold from Buy at Argus
      07:09 Today Argus
      AstraZeneca downgraded to Hold from Buy at Argus
      04/07/21 Citi
      FibroGen update creates only 'bad optic' for AstraZeneca, says Citi
      03/26/21 Piper Sandler
      AstraZeneca plan 'opens the door' for Altimmune interest, says Piper Sandler
      RHHBY Roche
      $41.93 /

      +0.53 (+1.28%)

      03/29/21 RBC Capital
      PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
      03/25/21 Wedbush
      iTeos Therapeutics price target raised to $52 from $46 at Wedbush
      03/23/21 Truist
      Truist sees mixed readthroughs to Wave's toplines from competitor HD setback
      03/23/21 BMO Capital
      Ionis Pharmaceuticals price target lowered to $76 from $90 at BMO Capital
      SGEN Seagen
      $142.81 /

      -1.68 (-1.16%)

      03/30/21 Credit Suisse
      Seagen initiated with a Neutral at Credit Suisse
      03/30/21 Credit Suisse
      Seagen initiated with a Neutral at Credit Suisse
      02/16/21 RBC Capital
      Seagen price target lowered to $169 from $186 at RBC Capital
      02/12/21 Barclays
      Seagen price target lowered to $168 from $177 at Barclays
      AGEN Agenus
      $2.78 /

      -0.01 (-0.36%)

      MRK Merck
      $76.33 /

      +0.855 (+1.13%)

      BMY Bristol-Myers
      $62.61 /

      +0.695 (+1.12%)

      AZN AstraZeneca
      $49.95 /

      +0.465 (+0.94%)

      RHHBY Roche
      $41.93 /

      +0.53 (+1.28%)

      SGEN Seagen
      $142.81 /

      -1.68 (-1.16%)

      MRK Merck
      $76.33 /

      +0.855 (+1.13%)

      BMY Bristol-Myers
      $62.61 /

      +0.695 (+1.12%)

      AZN AstraZeneca
      $49.95 /

      +0.465 (+0.94%)

      RHHBY Roche
      $41.93 /

      +0.53 (+1.28%)

      MRK Merck
      $76.33 /

      +0.855 (+1.13%)

      BMY Bristol-Myers
      $62.61 /

      +0.695 (+1.12%)

      AZN AstraZeneca
      $49.95 /

      +0.465 (+0.94%)

      RHHBY Roche
      $41.93 /

      +0.53 (+1.28%)

      SGEN Seagen
      $142.81 /

      -1.68 (-1.16%)

      MRK Merck
      $76.33 /

      +0.855 (+1.13%)

      BMY Bristol-Myers
      $62.61 /

      +0.695 (+1.12%)

      AZN AstraZeneca
      $49.95 /

      +0.465 (+0.94%)

      Hot Stocks
      Homology Medicines announces promotion of Tim Kelly to COO » 08:32
      04/12/21
      04/12
      08:32
      04/12/21
      08:32
      FIXX

      Homology Medicines

      $7.30 /

      -0.17 (-2.28%)

      Homology Medicines…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      03/01/21 Stifel
      Homology Medicines initiated with a Hold at Stifel
      03/01/21 Oppenheimer
      Homology Medicines loses potential source of upside, says Oppenheimer
      12/14/20 H.C. Wainwright
      Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
      11/08/20 Oppenheimer
      Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      • 07
        Apr
      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      Hot Stocks
      Homology Medicines announces promotion of Tim Kelly to COO » 08:32
      04/12/21
      04/12
      08:32
      04/12/21
      08:32
      FIXX

      Homology Medicines

      $7.30 /

      -0.17 (-2.28%)

      Homology Medicines…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      03/01/21 Stifel
      Homology Medicines initiated with a Hold at Stifel
      03/01/21 Oppenheimer
      Homology Medicines loses potential source of upside, says Oppenheimer
      12/14/20 H.C. Wainwright
      Homology Medicines transferred with Buy, $30 target at H.C. Wainwright
      11/08/20 Oppenheimer
      Homology Medicines selloff unjustified in wake of clinical PoC, says Oppenheimer
      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      • 07
        Apr
      FIXX Homology Medicines
      $7.30 /

      -0.17 (-2.28%)

      Hot Stocks
      Microsoft to acquire Nuance for $56.00 per share in cash  08:32
      04/12/21
      04/12
      08:32
      04/12/21
      08:32
      MSFT

      Microsoft

      $255.73 /

      +2.37 (+0.94%)

      , NUAN

      Nuance

      $45.59 /

      +0.38 (+0.84%)

       
      ShowHide Related Items >><<
      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      08:30 Today Stifel
      Microsoft a 'logical buyer' of Nuance, says Stifel
      07:36 Today B. Riley
      Nuance possible takeout positive for peer LivePerson, says B. Riley
      07:29 Today Wedbush
      Nuance deal would be 'trophy' for Microsoft, says Wedbush
      07:11 Today BMO Capital
      Microsoft price target raised to $280 from $270 at BMO Capital
      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      08:30 Today Stifel
      Microsoft a 'logical buyer' of Nuance, says Stifel
      07:36 Today B. Riley
      Nuance possible takeout positive for peer LivePerson, says B. Riley
      07:29 Today Wedbush
      Nuance deal would be 'trophy' for Microsoft, says Wedbush
      03/10/21 Wedbush
      Nuance added to Best Ideas List at Wedbush
      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      Recommendations
      Microsoft a 'logical buyer' of Nuance, says Stifel » 08:30
      04/12/21
      04/12
      08:30
      04/12/21
      08:30
      NUAN

      Nuance

      $45.59 /

      +0.38 (+0.84%)

      , MSFT

      Microsoft

      $255.73 /

      +2.37 (+0.94%)

      After Bloomberg reported…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      07:36 Today B. Riley
      Nuance possible takeout positive for peer LivePerson, says B. Riley
      07:29 Today Wedbush
      Nuance deal would be 'trophy' for Microsoft, says Wedbush
      03/10/21 Wedbush
      Nuance added to Best Ideas List at Wedbush
      03/08/21 Morgan Stanley
      Software industry rating raised to Attractive from In-Line at Morgan Stanley
      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      07:36 Today B. Riley
      Nuance possible takeout positive for peer LivePerson, says B. Riley
      07:29 Today Wedbush
      Nuance deal would be 'trophy' for Microsoft, says Wedbush
      07:11 Today BMO Capital
      Microsoft price target raised to $280 from $270 at BMO Capital
      04/09/21 BTIG
      Okta upgraded to Buy from Neutral at BTIG
      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      NUAN Nuance
      $45.59 /

      +0.38 (+0.84%)

      MSFT Microsoft
      $255.73 /

      +2.37 (+0.94%)

      Options
      Five new option listings on April 12th » 08:30
      04/12/21
      04/12
      08:30
      04/12/21
      08:30
      ACVA

      ACV Auctions

      $31.29 /

      -0.31 (-0.98%)

      , DSEY

      Diversey

      $14.79 /

      -0.12 (-0.80%)

      , RICE

      Rice Acquisition

      $17.25 /

      +1.94 (+12.67%)

      , TDUP

      thredUP

      $18.44 /

      +0.07 (+0.38%)

      , ULCC

      Frontier Group

      $21.35 /

      +0.08 (+0.38%)

      New option listings for…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      RICE Rice Acquisition
      $17.25 /

      +1.94 (+12.67%)

      ACVA ACV Auctions
      $31.29 /

      -0.31 (-0.98%)

      03/29/21 Northcoast
      ACV Auctions initiated with a Neutral at Northcoast
      DSEY Diversey
      $14.79 /

      -0.12 (-0.80%)

      RICE Rice Acquisition
      $17.25 /

      +1.94 (+12.67%)

      TDUP thredUP
      $18.44 /

      +0.07 (+0.38%)

      ULCC Frontier Group
      $21.35 /

      +0.08 (+0.38%)

      • 01
        Apr
      • 26
        Mar
      • 25
        Mar
      • 24
        Mar
      ACVA ACV Auctions
      $31.29 /

      -0.31 (-0.98%)

      DSEY Diversey
      $14.79 /

      -0.12 (-0.80%)

      RICE Rice Acquisition
      $17.25 /

      +1.94 (+12.67%)

      TDUP thredUP
      $18.44 /

      +0.07 (+0.38%)

      ULCC Frontier Group
      $21.35 /

      +0.08 (+0.38%)

      Conference/Events
      Oncolytics to hold a Key Opinion Leader conference call » 08:28
      04/12/21
      04/12
      08:28
      04/12/21
      08:28
      ONCY

      Oncolytics

      $3.99 /

      -0.61 (-13.26%)

      Management holds a Key…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return in 9 minutes

      Get Free Trial

      ShowHide Related Items >><<
      ONCY Oncolytics
      $3.99 /

      -0.61 (-13.26%)

      ONCY Oncolytics
      $3.99 /

      -0.61 (-13.26%)

      02/17/21 H.C. Wainwright
      Oncolytics initiated with a Buy at H.C. Wainwright
      05/11/20 RBC Capital
      Oncolytics price target lowered to C$6 from C$9 at RBC Capital
      ONCY Oncolytics
      $3.99 /

      -0.61 (-13.26%)

      Periodicals
      Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says » 08:27
      04/12/21
      04/12
      08:27
      04/12/21
      08:27
      PFE

      Pfizer

      $36.60 /

      +0.64 (+1.78%)

      , BNTX

      BioNTech

      $122.15 /

      +7.68 (+6.71%)

      The coronavirus variant…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
      PFE Pfizer
      $36.60 /

      +0.64 (+1.78%)

      BNTX BioNTech
      $122.15 /

      +7.68 (+6.71%)

      PFE Pfizer
      $36.60 /

      +0.64 (+1.78%)

      04/09/21
      Pfizer to host conference call
      04/06/21 RBC Capital
      Pfizer transferred with a Sector Perform at RBC Capital
      03/17/21 Mizuho
      AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
      02/23/21 B. Riley Securities
      B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
      BNTX BioNTech
      $122.15 /

      +7.68 (+6.71%)

      02/23/21 B. Riley Securities
      B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
      02/01/21 SVB Leerink
      Moderna price target raised to $80 from $69 at SVB Leerink
      01/29/21 Piper Sandler
      Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
      01/14/21 Morgan Stanley
      80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
      PFE Pfizer
      $36.60 /

      +0.64 (+1.78%)

      • 23
        Jul
      PFE Pfizer
      $36.60 /

      +0.64 (+1.78%)

      BNTX BioNTech
      $122.15 /

      +7.68 (+6.71%)

      PFE Pfizer
      $36.60 /

      +0.64 (+1.78%)

      BNTX BioNTech
      $122.15 /

      +7.68 (+6.71%)

      PFE Pfizer
      $36.60 /

      +0.64 (+1.78%)

      BNTX BioNTech
      $122.15 /

      +7.68 (+6.71%)

      Get Full Fly Access

      Breaking market intelligence sent straight to you
      Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
      Up-to-date information on important industry events
      Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
      News focused on the companies in your portfolio
      Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.